Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$32.06 USD
-0.40 (-1.23%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $32.05 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$32.06 USD
-0.40 (-1.23%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $32.05 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
Zacks News
PHG vs. HAE: Which Stock Is the Better Value Option?
by Zacks Equity Research
PHG vs. HAE: Which Stock Is the Better Value Option?
Are Investors Undervaluing Koninklijke Philips (PHG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Philips (PHG) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Philips' (PHG) first-quarter results benefit from strong momentum across the Diagnosis & Treatment and Personal Health businesses. However, softness in the Connected Care business is a concern.
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
by Zacks Equity Research
Philips (PHG) receives a warning letter from the FDA in respect of a manufacturing plant in China regarding faults in the manufacturing of CT systems.
Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries
by Zacks Equity Research
Philips (PHG) announces the FDA clearance for its Zenition 30 mobile C-arm, which is intended to aid in image-guided procedures at a relatively affordable cost.
Philips (PHG) Agrees to a Consent Decree With DOJ and FDA
by Zacks Equity Research
Philips (PHG) announces a consent decree with the U.S. government and FDA over Respironics' business recalls.
Philips (PHG) Boosts Patient Monitoring With smartQare Deal
by Zacks Equity Research
Philips (PHG) partners with smartQare to integrate the latter's viQtor solution, boosting its patient monitoring solutions portfolio.
Philips (PHG) Expands Sonicare Portfolio With Latest Launch
by Zacks Equity Research
Philips (PHG) adds Philips One for Kids toothbrush into its Sonicare family, boosting its Personal Health business.
Philips (PHG), AWS Unite to Scale Digital Pathology Solutions
by Zacks Equity Research
Philips (PHG) collaborates with Amazon Web Services to boost cloud-based pathology solutions. It will enable pathology laboratories to use digital processes to improve analytical capabilities.
Philips (PHG) Aids Personal Health Business With New Campaign
by Zacks Equity Research
Philips (PHG) launches #ShareTheCare brand positioning campaign for Philips Avent, bolstering the Personal Health segment.
Philips (PHG), SyntheticMR Unite to Aid Brain Diagnosing Space
by Zacks Equity Research
Philips (PHG) and SyntheticMR collaborate to launch of Smart Quant Neuro 3D, which is likely to boost the brain diagnosing field by providing automatic and precise 3D segmentation of brain tissues.
Philips' (PHG) CT 5300 to Boost Diagnostic Capabilities
by Zacks Equity Research
Philips (PHG) announces its latest innovation, Philips CT 5300, which leverages the power of AI at every stage in CT scanner operation to enhance productivity and diagnostic capabilities.
Philips (PHG) Aids Diagnostic Imaging With Philips CT 5300
by Zacks Equity Research
Philips (PHG) introduces AI-enabled Philips CT 5300 X-ray CT system, expanding its diagnostic imaging portfolio.
Philips' (PHG) New Innovation to Boost Neurovascular Diagnosis
by Zacks Equity Research
Philips (PHG) announces its latest Azurion neuro biplane system, which aims to improve the diagnosis of stroke and major neurovascular diseases. The system is designed for superior patient care.
Philips' (PHG) New Innovation to Boost Radiation-Free Imaging
by Zacks Equity Research
Philips (PHG) announces its latest LumiGuide imaging technology, which is likely to pave the way for new radiation-free procedures. It will prove beneficial for complex aortic surgeries.
Philips (PHG) Receives FDA Class 1 Recall for BrightView SPECT
by Zacks Equity Research
Philips (PHG) receives an FDA Class 1 recall for BrightView imaging systems.
Philips' (PHG) New Innovation to Enhance Cardiovascular Imaging
by Zacks Equity Research
Philips' (PHG) latest X11-4t Mini 3D TEE transducer is likely to have an edge over the traditional 3D TEE in terms of catering to a broader range of patients and improved overall comfort.
Philips (PHG) Q4 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Philips' (PHG) fourth-quarter results benefit from strong momentum across the Diagnosis & Treatment and Personal Health businesses. However, softness in the Connected Care business is a concern.
What's in Store for Koninklijke Philips (PHG) in Q4 Earnings?
by Zacks Equity Research
Koninklijke Philips' (PHG) fourth-quarter results are likely to reflect solid momentum in the Diagnosis & Treatment and Connected Care segments.
Why Royal Philips (PHG) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Owens & Minor (OMI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Income Stocks to Buy for January 17th
by Zacks Equity Research
TRP, PHG and SPB made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 17, 2024.
New Strong Buy Stocks for January 17th
by Zacks Equity Research
SKWD, PHG, BK, PAGS and GMAB have been added to the Zacks Rank #1 (Strong Buy) List on January 17, 2024.
New Strong Buy Stocks for January 11th
by Zacks Equity Research
ADMA, ARQT, PHR, OPRX and PHG have been added to the Zacks Rank #1 (Strong Buy) List on January 11, 2024.